AA
MCRB icon

ALPS Advisors’s Seres Therapeutics MCRB Stock Holding History

ALPS Advisors’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,389
Closed -$435K – 1067
2022
Q3 		$435K Buy
3,389
+653
+24% +$66.9K ﹤0.01% 634
2022
Q2 		$188K Sell
2,736
-1,993
-42% -$172K ﹤0.01% 1003
2022
Q1 		$673K Sell
4,729
-585
-11% -$90K 0.01% 366
2021
Q4 		$885K Sell
5,314
-307
-5% -$48.8K 0.01% 378
2021
Q3 		$782K Sell
5,621
-377
-6% -$73.8K 0.01% 414
2021
Q2 		$2.86M Sell
5,998
-2,283
-28% -$963K 0.03% 227
2021
Q1 		$3.41M Buy
8,281
+771
+10% +$355K 0.03% 200
2020
Q4 		$3.68M Buy
+7,510
New +$4.4M 0.04% 195
2018
Q2 		– Sell
-2,718
Closed -$399K – 954
2018
Q1 		$399K Buy
2,718
+472
+21% +$90.5K ﹤0.01% 791
2017
Q4 		$455K Buy
2,246
+251
+13% +$51.6K ﹤0.01% 634
2017
Q3 		$640K Buy
1,995
+172
+9% +$47K ﹤0.01% 328
2017
Q2 		$412K Buy
1,823
+87
+5% +$17.9K ﹤0.01% 671
2017
Q1 		$391K Sell
1,736
-203
-10% -$41.2K ﹤0.01% 667
2016
Q4 		$384K Sell
1,939
-628
-24% -$137K ﹤0.01% 618
2016
Q3 		$631K Sell
2,567
-209
-8% -$73.3K 0.01% 246
2016
Q2 		$1.61M Buy
+2,776
New +$1.63M 0.01% 185

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

ALPS Advisors's MCRB Position: Q4 2022 in Review

ALPS Advisors sold out of Seres Therapeutics (MCRB) in Q4 2022, closing a stake of 3,389 shares — an estimated $435K sold.

ALPS Advisors first reported a position in MCRB in Q2 2016 and held it in 16 quarters. The position peaked at $3.68M in Q4 2020. 123 funds tracked by Wall St. Rank hold MCRB as of Q4 2022.

  • ALPS Advisors reported no remaining Seres Therapeutics position as of Q4 2022 after selling out during the quarter.
  • ALPS Advisors sold 3,389 Seres Therapeutics shares in Q4 2022, an estimated $435K.
  • ALPS Advisors first reported a position in Seres Therapeutics in Q2 2016 and held it in 16 quarters.
  • ALPS Advisors's Seres Therapeutics position peaked at $3.68M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2022.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.